Home
Clinical Resources Search
PQI: Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

Download PQI pdf

Last Updated: April 29, 2024

By: Jasmine Patel, PharmD, BCOP

About this PQI

The purpose of this PQI is to discuss the option of using bortezomib for first-line treatment in multiple myeloma (MM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E8: The Future of Oncology

S11 E7: Your Health Story in One Place

S11 E6: Finding the Heart of Oncology

S11 E5: Keep Marching On: Changing the Story of Pancreatic Cancer

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Melphalan Conditioning for Autologous Transplant

Talquetamab, Pomalidomide and Daratumumab/Hyaluronidase

Talquetamab and Daratumumab/Hyaluronidase

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

Cyclophosphamide, Bortezomib, and Dexamethasone

Belantamab Mafodotin and Vd

Daratumumab and CyBorD

Isatuximab and VRd